SCHEMBL10353115

SCHEMBL10353115

COc1c(Cl)cc(Cn2c(S)nc3ccccc32)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
HTT P42858 4/20 0.47
LMNA P02545 4/20 0.47
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
CNR2 P34972 1/20 0.47
TP53 P04637 5/20 0.46
MAPT P10636 3/20 0.46
NPSR1 Q6W5P4 3/20 0.46
HPGD P15428 2/20 0.46
RAB9A P51151 3/20 0.46
GALR3 O60755 1/20 0.46
NR2F2 P24468 1/20 0.46
TNF P01375 2/20 0.46
TSHR P16473 2/20 0.44
MAPK1 P28482 1/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C19 P33261 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10353112 0.85 CSF1R (0.47) SMN1; SMN2HTTLMNAALDH1A1KDM4E
SCHEMBL10353129 0.83 KMT2A (0.51) KMT2ALMNAALDH1A1TP53RAB9A
SCHEMBL10353137 0.81 KMT2A (0.71) KMT2ASMN1; SMN2HTTLMNAALDH1A1
SCHEMBL10353544 0.81 SMN1; SMN2 (0.69) SMN1; SMN2HTTLMNAALDH1A1KDM4E
SCHEMBL10353246 0.81 TNF (0.52) KMT2ASMN1; SMN2LMNAALDH1A1L3MBTL1
SCHEMBL5199559 0.79 TNF (0.65) KMT2ASMN1; SMN2HTTLMNAALDH1A1
SCHEMBL13258286 0.76 TP53 (0.67) KMT2ASMN1; SMN2HTTLMNAALDH1A1
SCHEMBL10353130 0.75 HTT (0.54) KMT2ASMN1; SMN2HTTLMNAALDH1A1
SCHEMBL10353551 0.74 MAPT (0.63) KMT2AHTTALDH1A1TP53MAPT
SCHEMBL10353872 0.74 RAB9A (0.50) KMT2ASMN1; SMN2HTTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0190817-B1 DOPAMINE-BETA-HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1990-09-05 EP claimed
EP-0190817-A1 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1986-08-13 EP claimed
EP-0190817-B1 DOPAMINE-BETA-HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1990-09-05 EP disclosed
US-4857540-A 1-SUBSTITUTED-2-MERCAPTO-(OR AMINOMETHYL-)BENZAMIDAZOLE COMPOUNDS SMITHKLINE BECKMAN CORPORATION (US) 1989-08-15 US disclosed
US-4728741-A DOPAMINE BETA-HYDROXYLASE INHIBITOR SMITHKLINE BECKMAN CORPORATION (US) 1988-03-01 US disclosed
EP-0190817-A1 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1986-08-13 EP disclosed